Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Urinary pH and stone formation.

Wagner CA, Mohebbi N.

J Nephrol. 2010 Nov-Dec;23 Suppl 16:S165-9. Review.

3.

Insulin resistance and low urinary citrate excretion in calcium stone formers.

Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.

Biomed Pharmacother. 2007 Jan;61(1):86-90. Epub 2006 Dec 4.

PMID:
17184967
4.

[Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].

Hochreiter W, Knoll T, Hess B.

Ther Umsch. 2003 Feb;60(2):89-97. German.

PMID:
12649987
5.

Diet-induced metabolic acidosis.

Adeva MM, Souto G.

Clin Nutr. 2011 Aug;30(4):416-21. doi: 10.1016/j.clnu.2011.03.008. Epub 2011 Apr 9. Review.

PMID:
21481501
6.

Optimum nutrition for kidney stone disease.

Heilberg IP, Goldfarb DS.

Adv Chronic Kidney Dis. 2013 Mar;20(2):165-74. doi: 10.1053/j.ackd.2012.12.001. Review.

PMID:
23439376
7.
8.

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.

Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K.

Kidney Int. 2004 Feb;65(2):386-92.

10.

[Functional evaluation in patients with kidney calculi].

Stojimirović B.

Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8. Review. Serbian.

PMID:
9863414
11.

Body size and 24-hour urine composition.

Taylor EN, Curhan GC.

Am J Kidney Dis. 2006 Dec;48(6):905-15.

PMID:
17162145
12.

Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.

Glauser A, Hochreiter W, Jaeger P, Hess B.

Nephrol Dial Transplant. 2000 Oct;15(10):1580-7.

PMID:
11007825
13.

Evaluation of factors involved in calcium stone formation.

Abraham PA, Smith CL.

Miner Electrolyte Metab. 1987;13(3):201-8.

PMID:
3627051
14.

Metabolic abnormalities associated with calyceal diverticular stones.

Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.

BJU Int. 2006 May;97(5):1053-6.

15.

Metabolic syndrome and uric acid nephrolithiasis.

Sakhaee K, Maalouf NM.

Semin Nephrol. 2008 Mar;28(2):174-80. doi: 10.1016/j.semnephrol.2008.01.010. Review.

PMID:
18359398
16.

Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?

Siener R.

Urolithiasis. 2016 Feb;44(1):51-6. doi: 10.1007/s00240-015-0844-7. Epub 2015 Nov 27. Review.

PMID:
26614113
17.

The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease.

Fellström B, Danielson BG, Karlström B, Lithell H, Ljunghall S, Vessby B.

Clin Sci (Lond). 1983 Apr;64(4):399-405.

PMID:
6825409
18.

[Renal tubular function in children with hypercalciuria].

Kovacević L, Kovacević S, Smoljanić Z, Kostić M, Peco-Antić A, Gajić M, Kovacević M, Jovanović O.

Srp Arh Celok Lek. 1998 Jul-Aug;126(7-8):223-7. Serbian.

PMID:
9863386
19.
20.

Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.

Sterrett SP, Penniston KL, Wolf JS Jr, Nakada SY.

Urology. 2008 Aug;72(2):278-81. doi: 10.1016/j.urology.2008.04.003. Epub 2008 Jun 4.

PMID:
18533229

Supplemental Content

Support Center